Surgery in Treating Children With Neuroblastoma
This study has been completed.
Children's Oncology Group
Information provided by:
National Cancer Institute (NCI)
First received: November 1, 1999
Last updated: June 14, 2012
Last verified: November 2010
Show Detailed Description
RATIONALE: Surgery alone may be effective in treating children with neuroblastoma.
PURPOSE: Phase III trial to study the effectiveness of surgery alone in treating children who have neuroblastoma.
Drug: doxorubicin hydrochloride
Procedure: adjuvant therapy
Procedure: conventional surgery
Radiation: radiation therapy
|Study Design:||Primary Purpose: Treatment|
|Official Title:||Primary Surgical Therapy for Biologically Defined Low-Risk Neuroblastoma: A Pediatric Oncology Group/Children's Cancer Group Intergroup Study|
Resource links provided by NLM:
Drug Information available for: Cyclophosphamide Doxorubicin Doxorubicin hydrochloride Etoposide Carboplatin Etoposide phosphate Filgrastim Sargramostim Lenograstim Granulocyte colony-stimulating factorU.S. FDA Resources
Further study details as provided by National Cancer Institute (NCI):
|Study Start Date:||March 1998|
|Primary Completion Date:||March 2006 (Final data collection date for primary outcome measure)|
Contacts and Locations